Effects of dietary approaches to stop hypertension on the quality of life and re-hospitalization rate in patients with chronic heart failure
10.3760/cma.j.issn.1674-2907.2018.07.019
- VernacularTitle:DASH饮食疗法对慢性心力衰竭患者生活质量和再住院率的影响
- Author:
Lili SUN
1
;
Can ZHANG
;
Chunyan MA
;
Ximei TIAN
Author Information
1. 郑州大学第一附属医院综合医学部
- Keywords:
Quality of life;
Chronic heart failure;
DASH diet;
Re-hospitalization rate
- From:
Chinese Journal of Modern Nursing
2018;24(7):822-825
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of dietary approaches to stop hypertension (DASH) on the quality of life and re-hospitalization rate in patients with chronic heart failure (CHF). Methods A total of 163 patients with CHF receiving standard medical therapy in the Cardiology Department of the First Affiliated Hospital of Zhengzhou University from February to September 2014 were selected and divided into experimental group (n=85) and control group (n=78) randomly. Low salt, low fat diet was applied in the control group, while DASH was adopted in the experimental group. Patients' body mess index (BMI), blood pressure, blood glucose, blood lipid, ejection fraction, cardiac function, the score of Minnesota Living with Heart Failure Questionnaire (MLHFQ) and re-hospitalization rate were compared before and after intervention. Results There were no statistical differences in BMI, blood pressure, blood glucose, blood lipid, cardiac function and the score of MLHFQ before intervention (P> 0.05). Patients' BMI, systolic pressure, cholesterol and triglyceride of the experimental group paitents were all lower than those of the control group 12 months after intervention, with statistical significance (P< 0.05). 12 months after intervention, patients' quality of life of the experimental group was higher than that of the control group (P<0.05), and the re-hospitalization rate was lower than that of the control group (P<0.05). Conclusions DASH can improve the quality of life in patients with CHF, reduce readmission rate, thus improving the prognosis of heart failure.
